Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.5B | 14.2B | 13.0B | 13.6B |
Cost of revenue | 11.4B | 10.0B | 9.4B | 9.4B |
Gross profit | 5.1B | 4.2B | 3.6B | 4.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 191M | 630M | 186M | 164M |
Other operating expenses | 117M | 71M | 70M | 102M |
Operating income | 4.2B | 3.0B | 2.9B | 3.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 299M | 276M | 269M | 278M |
Other income expense | 547M | -123M | 593M | 475M |
Pretax income | 4.5B | 3.0B | 3.2B | 3.7B |
Tax provision | 1.6B | 664M | 1.2B | 1.3B |
Net income | 2.8B | 2.3B | 2.1B | 2.3B |
Basic EPS | 2.2 | 1.9 | 1.8 | 2.0 |
Diluted EPS | 2.2 | 1.9 | 1.8 | 2.0 |
Basic average shares | 1.4B | 1.4B | 1.3B | 1.3B |
Diluted average shares | 1.4B | 1.4B | 1.3B | 1.3B |
EBITDA | 7.5B | 6.0B | 5.9B | 6.3B |
Net income from continuing op. | 2.8B | 2.3B | 2.1B | 2.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | 9M | — | — | 7M |